Rosenblum Silverman Sutton’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.18M | Sell |
18,683
-180
| -1% | -$97.7K | 2.4% | 16 |
|
|
2025
Q4 | $10.9M | Sell |
18,863
-324
| -2% | -$183K | 2.53% | 14 |
|
|
2025
Q3 | $9.31M | Buy |
19,187
+18
| +0.1% | +$8.38K | 2.12% | 16 |
|
|
2025
Q2 | $7.77M | Sell |
19,169
-276
| -1% | -$115K | 1.88% | 15 |
|
|
2025
Q1 | $9.68M | Buy |
19,445
+223
| +1% | +$121K | 2.67% | 11 |
|
|
2024
Q4 | $10M | Sell |
19,222
-743
| -4% | -$409K | 2.51% | 14 |
|
|
2024
Q3 | $12.3M | Sell |
19,965
-129
| -0.6% | -$76.4K | 3.16% | 12 |
|
|
2024
Q2 | $11.1M | Buy |
20,094
+5
| +0% | +$2.86K | 2.98% | 13 |
|
|
2024
Q1 | $11.7M | Sell |
20,089
-99
| -0.5% | -$55.6K | 3.31% | 12 |
|
|
2023
Q4 | $10.7M | Sell |
20,188
-38
| -0.2% | -$18.4K | 3.41% | 10 |
|
|
2023
Q3 | $10.2M | Sell |
20,226
-88
| -0.4% | -$46.9K | 3.49% | 8 |
|
|
2023
Q2 | $10.6M | Sell |
20,314
-669
| -3% | -$361K | 3.5% | 7 |
|
|
2023
Q1 | $12.1M | Sell |
20,983
-4,795
| -19% | -$2.7M | 4.41% | 4 |
|
|
2022
Q4 | $14.2M | Sell |
25,778
-694
| -3% | -$368K | 5.17% | 3 |
|
|
2022
Q3 | $13.4M | Sell |
26,472
-2,062
| -7% | -$1.15M | 4.85% | 4 |
|
|
2022
Q2 | $15.5M | Sell |
28,534
-460
| -2% | -$253K | 5.04% | 3 |
|
|
2022
Q1 | $17.1M | Sell |
28,994
-560
| -2% | -$322K | 4.38% | 5 |
|
|
2021
Q4 | $19.7M | Sell |
29,554
-1,379
| -4% | -$861K | 4.44% | 5 |
|
|
2021
Q3 | $17.7M | Sell |
30,933
-905
| -3% | -$497K | 4.04% | 6 |
|
|
2021
Q2 | $16.1M | Buy |
31,838
+10
| +0% | +$4.72K | 3.61% | 9 |
|
|
2021
Q1 | $14.5M | Sell |
31,828
-178
| -0.6% | -$85K | 3.73% | 8 |
|
|
2020
Q4 | $14.9M | Sell |
32,006
-240
| -0.7% | -$113K | 3.88% | 8 |
|
|
2020
Q3 | $14.2M | Buy |
32,246
+640
| +2% | +$264K | 4% | 7 |
|
|
2020
Q2 | $11.5M | Sell |
31,606
-227
| -0.7% | -$76.1K | 3.68% | 10 |
|
|
2020
Q1 | $9.03M | Sell |
31,833
-1,162
| -4% | -$366K | 3.61% | 9 |
|
|
2019
Q4 | $10.7M | Sell |
32,995
-431
| -1% | -$131K | 3.91% | 6 |
|
|
2019
Q3 | $9.74M | Sell |
33,426
-769
| -2% | -$220K | 3.75% | 6 |
|
|
2019
Q2 | $10M | Sell |
34,195
-951
| -3% | -$262K | 3.81% | 7 |
|
|
2019
Q1 | $9.62M | Buy |
35,146
+26,113
| +289% | +$6.5M | 3.81% | 6 |
|
|
2018
Q4 | $962K | Sell |
9,033
-29,940
| -77% | -$7.02M | 0.44% | 46 |
|
|
2018
Q3 | $9.51M | Sell |
38,973
-1,391
| -3% | -$320K | 3.15% | 11 |
|
|
2018
Q2 | $8.36M | Sell |
40,364
-2,533
| -6% | -$538K | 2.9% | 11 |
|
|
2018
Q1 | $8.86M | Sell |
42,897
-1,427
| -3% | -$300K | 3.15% | 9 |
|
|
2017
Q4 | $8.42M | Sell |
44,324
-147
| -0.3% | -$28.2K | 3.02% | 8 |
|
|
2017
Q3 | $8.41M | Buy |
44,471
+513
| +1% | +$92.9K | 3.19% | 9 |
|
|
2017
Q2 | $7.67M | Buy |
43,958
+145
| +0.3% | +$24.4K | 3.06% | 9 |
|
|
2017
Q1 | $6.73M | Buy |
43,813
+669
| +2% | +$102K | 2.85% | 9 |
|
|
2016
Q4 | $6.09M | Sell |
43,144
-194
| -0.4% | -$28.6K | 2.88% | 9 |
|
|
2016
Q3 | $6.89M | Sell |
43,338
-695
| -2% | -$107K | 3.16% | 8 |
|
|
2016
Q2 | $6.51M | Buy |
+44,033
| New | +$6.5M | 3.12% | 6 |
|
|
2015
Q4 | $6.48M | Sell |
45,687
-3,215
| -7% | -$429K | 2.96% | 10 |
|
|
2015
Q3 | $5.98M | Sell |
48,902
-3,150
| -6% | -$410K | 2.85% | 11 |
|
|
2015
Q2 | $6.75M | Buy |
+52,052
| New | +$6.79M | 2.7% | 9 |
|
|
2014
Q4 | $6.48M | Sell |
51,726
-280
| -0.5% | -$34K | 2.79% | 10 |
|
|
2014
Q3 | $6.33M | Buy |
52,006
+1,355
| +3% | +$165K | 2.85% | 9 |
|
|
2014
Q2 | $5.98M | Sell |
50,651
-155
| -0.3% | -$18.2K | 2.79% | 10 |
|
|
2014
Q1 | $6.11M | Buy |
50,806
+1,385
| +3% | +$165K | 2.9% | 8 |
|
|
2013
Q4 | $5.5M | Sell |
49,421
-645
| -1% | -$64.1K | 2.6% | 11 |
|
|
2013
Q3 | $4.61M | Buy |
+50,066
| New | +$4.53M | 2.47% | 14 |
|
Other funds holding TMO
VCM
Rosenblum Silverman Sutton's TMO Position: Q1 2026 in Review
Rosenblum Silverman Sutton reduced its Thermo Fisher Scientific (TMO) stake by 0.95% in Q1 2026, selling an estimated $97.7K and leaving 18,683 shares worth $9.18M. The position accounts for 2.4% of the portfolio, ranked #16.
Rosenblum Silverman Sutton first reported a position in TMO in Q3 2013 and has held it in 49 quarters since. The position peaked at $19.7M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Rosenblum Silverman Sutton held 18,683 shares of Thermo Fisher Scientific worth $9.18M as of Q1 2026.
- Rosenblum Silverman Sutton sold 180 Thermo Fisher Scientific shares in Q1 2026, an estimated $97.7K.
- Thermo Fisher Scientific made up 2.4% of Rosenblum Silverman Sutton's portfolio in Q1 2026, its #16 holding.
- Rosenblum Silverman Sutton first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 49 quarters since.
- Rosenblum Silverman Sutton's Thermo Fisher Scientific position peaked at $19.7M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Rosenblum Silverman Sutton's 13F filing for Q1 2026, filed 13 May 2026.